C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia
- 1 January 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 36 (1) , 166-171
Abstract
Objective: Appropriateness of antibiotic therapy is associated with reduction of bacterial load in ventilator-associated pneumonia. C-reactive protein is a valid biochemical surrogate. The objective was to determine the correlation of bacterial load, measured by quantitative tracheal aspirate (QTA), with serum C-reactive protein as an indicator of inflammatory response in episodes of ventilator-associated pneumonia and association of its variation with antibiotic appropriateness. Design: Prospective, observational cohort study. Setting: Two medical-surgical intensive care units at large urban hospitals affiliated with teaching institutions. Patients: Sixty-eight intubated patients with monomicrobial ventilator-associated pneumonia. Interventions: None. Measurements and Main Results: QTA and serum C-reactive protein were measured in patients with suspected ventilator-associated pneumonia on diagnosis (baseline) and 96 hrs afterward (follow-up). Its logarithm value (logQTA) was calculated. LogQTA correlated positively with serum C-reactive protein (ρ = 0.46, p < .05), temperature (ρ = 0.20, p = .05), and white blood cell count (ρ = 0.22, p < .05). LogQTA decreased significantly more from baseline to follow-up in patients receiving appropriate empirical antibiotic therapy compared with those with inappropriate treatment (logQTA ratio 0.77 ± 0.22 vs. 1.02 ± 0.27, p < .05). Mean serum C-reactive protein levels showed a similar pattern, decreasing from baseline to follow-up in patients receiving appropriate empirical antibiotic treatment but not in episodes with inappropriate treatment (C-reactive protein ratio 0.58 ± 0.32 vs. 1.36 ± 1.11, p < .05). There was a positive correlation between serum C-reactive protein and logQTA variations (r2 = .59, p < .05). Adjusted mean serum C-reactive protein levels by analysis of covariance on follow-up were significantly lower in patients with appropriate antibiotic treatment than in those with inappropriate empirical treatment (103 ± 10 mg/L vs. 192 ± 14 mg/L, p < .05). A C-reactive protein ratio of 0.8 at 96 hrs was a useful indicator of appropriateness of antibiotic therapy (sensitivity 77%; specificity 87%; area under the receiver operating characteristic curve 0.86 [0.75–0.96]). Conclusions: C-reactive protein is a useful biochemical surrogate of bacterial burden in patients with ventilator-associated pneumonia. Follow-up measurements of serum C-reactive protein anticipate the appropriateness of antibiotic therapy.Keywords
This publication has 23 references indexed in Scilit:
- Invasive approaches to the diagnosis of ventilator-associated pneumonia: A meta-analysisCritical Care Medicine, 2005
- Procalcitonin Kinetics as a Prognostic Marker of Ventilator-associated PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Soluble Triggering Receptor Expressed on Myeloid Cells and the Diagnosis of PneumoniaNew England Journal of Medicine, 2004
- Ventilator-Associated Pneumonia Patients who Do Not Reduce Bacteria from the Lungs have a Worse PrognosisJournal of Intensive Care Medicine, 2003
- Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US DatabaseChest, 2002
- Diagnosis and follow-up of infections in intensive care patients: Value of C-reactive protein compared with other clinical and biological variables*Critical Care Medicine, 2002
- Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumoniaClinical Microbiology and Infection, 2002
- Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumoniaCritical Care Medicine, 2000
- Noninvasive Versus Invasive Microbial Investigation in Ventilator-associated PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Incidence of and Risk Factors for Ventilator-Associated Pneumonia in Critically Ill PatientsAnnals of Internal Medicine, 1998